openPR Logo
Press release

Drug Delivery Devices Market Study By 2025 With Sanofi, Pfizer, Merck, 3M, Roche, Johnson & Johnson, Bayer, Alkermes, Abbott Healthcare, Novartis

10-12-2018 04:19 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Drug Delivery Devices Industry Analysis 2018

Drug Delivery Devices Industry Analysis 2018

The drug delivery devices market report is a complete overview of the market, covering various aspects product definition, segmentation based on various parameters, and the prevailing vendor landscape. Report analyzed drug delivery devices market data like capacity, production, capacity utilization rate, price, revenue, cost, gross, gross margin, supply, import, export, consumption, market share, growth rate and etc. The global drug delivery devices market report also contains the drivers and restrains for the market that are derived from SOWT analysis, and also shows what all the recent developments, product launches, joint ventures, merges and accusations by the several key players and brands that are driving the market are by systemic company profiles.

The Global Drug Delivery Devices Market accounted to USD 1,027.0 billion and growing at a CAGR of 8.1% during the forecast period.

Get Sample Analysis of This Market Information: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-delivery-devices-market

Report Forecasting Regional and Global Analysis on Drug Delivery Devices Market By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies) and Geography.

Drug delivery is the process of administering a pharmaceutical compound into the body for a therapeutic effect through various routes. Drug delivery improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by bypassing first-pass metabolism. The Global Drug Delivery Devices Market is highly fragmented and is based on new product launches and clinical results of products. Some of the major players operating in Drug Delivery Devices market are

· 3M Company,

· Merck & Co., Inc.,

· Pfizer Inc,

· Johnson & Johnson,

· Bayer AG,

· F. Hoffmann-La Roche AG,

· Sanofi,

· Alkermes,

· Abbott,

· Novartis AG,

Others: Valeant Pharmaceuticals International, Inc., Mylan Pharmaceuticals Inc., Antares Pharma, Skye Pharma Plc., Nova Nordisk A/S, Crossject, Eli Lilly and Company, Baxter International, Inc., Becton, Dickinson and Company, Skyepharma AG amongst others. The report includes market shares of Global Drug Delivery Devices Market for global, Europe, North America, Asia Pacific and South America. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

Get TOC of Full Report: https://databridgemarketresearch.com/toc/?dbmr=global-drug-delivery-devices-market


· By product type, the global drug delivery devices market is segmented into

o Oral

o Pulmonary

o Injectable

o Ocular

o Nasal

o Topical

o Implantable

o Transmucosal

· Oral Drug Delivery is then segmented on the basis of form into solid oral drugs, liquid oral drugs and semi-solid oral drugs. The form of solid oral drugs is further sub segmented into tablets, capsules, powders, and pills.

· Liquid oral drug is sub segmented into solutions and syrups. Semi-solid oral drug is sub segmented into gels, emulsions and elixirs.

· Pulmonary Drug Delivery is segmented on the basis of formulations, devices and nebulizers. On the basis of device the pulmonary drug delivery segment is further sub-segmented into in metered dose inhalers and dry powder inhaler. Nebulizers are sub segmented into Jet Nebulizers, Ultrasonic Nebulizers and Soft Mist Nebulizers.

· The injectable drug delivery segment is further segmented on the basis of product type and formulations. On the basis of type, the injectable drug delivery is segmented into self-injection devices, needle free injectors, auto-injectors, pen-injectors, wearable injectors. On the basis of formulations the market is segmented into conventional drug delivery formulations, novel drug delivery formulations and long acting injection formulations.

· The ophthalmic drug delivery is segmented on the basis of product type – ocular drug delivery devices and ocular drug delivery formulations. The ocular drug delivery is further segmented by product type, drug coated contact lenses and ocular inserts. The ocular drug delivery formulations is further segmented into liquid ocular drug delivery formulations and semi-solid ocular drug delivery formulations. On the basis of type the liquid ocular drug delivery formulations is further sub segmented into eye drops and sprays. On the basis of type the semi-solid ocular drug delivery formulations is sub segmented into gels and ointments.

· The nasal drug delivery is segmented by type in nasal drops, nasal sprays, nasal powders and nasal gels.

· The topical drug delivery is segmented on the basis of product type, transdermal drug delivery devices and topical drug delivery formulations. On the basis of product type the transdermal drug delivery devices is further sub segmented in transdermal patches and transdermal gels.

· On the basis of forms the topical drug delivery formulations are sub segmented into liquid topical drug delivery formulations, semi-solid topical drug delivery formulations, and solid topical drug delivery formulations.

· The liquid topical drug delivery formulations are further sub segmented into solutions and suspensions. The semi-solid topical drug delivery formulations are further sub segmented by type into creams, gels, ointments, pastes and lotions. On the basis of type the solid topical drug delivery formulations is further sub segmented into suppositories and powders.

· The implantable drug delivery is segmented by product type, activeimplantable drug delivery and passive implantable drug delivery.

· On the basis of product type the transmucosal drug delivery is segmented in oral transmucosal drug delivery and other transmucosal drug delivery. On the basis of type the oral transmucosal drug delivery is further sub segmented into buccal drug delivery and sublingual drug delivery. The other transmucosal drug delivery is further sub segmented into rectal transmucosal drug delivery and vaginal transmucosal drug delivery.

· On the basis of end users the market is segmented into

o Hospitals,

o Home healthcare,

o Clinics,

o Community healthcare and others.

· On the basis of distribution channel the market is segmented in

o Hospital pharmacies

o Pharmacy stores

o Direct tenders

· On the basis of geography, drug delivery devices market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa.

· Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., China, India, Japan, Australia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Major Market Drivers and Restraints:

· Growth in the number of diseases.

· Rise in Biologics Market

· Technological Advancement and New Product Launches are the factors which drives the market.

· Alternative drug delivery methods.

· Needlestick injuries & infections and Side Effects of Drugs.

· Regulatory requirements for the approval of devices restrain the market.

· Rising Demand for Biosimilars and Generic Drugs is the opportunity for the market.

· Pricing pressure is the challenge for the market.


Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-delivery-devices-market

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization and Getting Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Devices Market Study By 2025 With Sanofi, Pfizer, Merck, 3M, Roche, Johnson & Johnson, Bayer, Alkermes, Abbott Healthcare, Novartis here

News-ID: 1300698 • Views: 565

More Releases from Data Bridge Market Research

Cardiac Computed Tomography (CCT) Market Size, Share Research Report to 2027| CA …
Cardiac Computed Tomography (CCT) Market analysis report comprises of data that can be pretty essential when it comes to dominating the market or making a mark in the Cardiac Computed Tomography (CCT) Industry as a new emergent. This report has a lot to offer such as the general market conditions, industry share, size, demand, trends, inclinations, key players, opportunities, geographical analysis and many other parameters that helps to take business
Hemostasis Valve Market Key Players Analysis-Boston Scientific Corporation; Abbo …
Hemostasis Valve Market report provides the understanding of the most affecting driving and restraining forces in the market and its impact on the global market. This report aids in assessing production processes, major issues, and solutions to mitigate the development risk. The market experts preparing this report have deeply profiled leading as well as other players of the global Hemostasis Valve Market with large emphasis on their market share, recent
Building Automation System Market To See Astonishing Growth } Leading Players Ar …
This Building Automation System market research report studies key opportunities in the market and influencing factors that are valuable for the businesses. This Building Automation System analysis puts a light on various segments that are relied upon to witness the quickest business development amid the estimate forecast frame. All the statistical and numerical data, which is calculated with the most established tools such as SWOT analysis, is represented with the
Cell Analysis Market Leading Company Analysis by Size, Share, Types, Application …
The Cell Analysis Market 2020 report comprehensively studies market definition, market segmentation, competitive analysis and key developments in the market. It comprises of fundamental, secondary and advanced information related to the global status and trend, market size, sales volume, industry share, growth, future trends analysis, segment and forecasts from 2020-2027. It includes an extensive research on the current conditions of the industry, potential of the market in the present and

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning